Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Quincy Bioscience Manufacturing Inc.
WARNING LETTER
•Quincy Bioscience Manufacturing Inc.•December 22, 2011

Quincy Bioscience Manufacturing Inc. – FDA Warning Letter, Dec 22, 2011

Record Details

The FDA issued a Warning Letter to Quincy Bioscience Manufacturing Inc. for marketing Prevagen products (Prevagen, Prevagen Extra Strength, Prevagen Professional) as unapproved new drugs and misbranded drugs.

The FDA reviewed the company's websites in August 2012 and determined that therapeutic claims, such as "protects the brain cells from death" and testimonials about improving Alzheimer's and head injury memory loss, establish the products as drugs intended for disease treatment or prevention under 21 U.S.C. § 321(g)(1)(B). Additionally, the company sponsored clinical trials for apoaequorin without an Investigational New Drug (IND) application, violating 21 U.S.C. §§ 331(d) and 355(a) and 21 CFR Part 312.

The FDA also found that the synthetically produced apoaequorin in Prevagen products is not a "dietary ingredient" as defined by 21 U.S.C. § 321(ff)(1), meaning the products do not qualify as dietary supplements. Since the products are unapproved new drugs, they are also misbranded under 21 U.S.C. § 352(f)(1) because they lack adequate directions for layperson use.

An inspection from October to December 2011 revealed the company failed to report

Company
Quincy Bioscience Manufacturing Inc.
Inspection date
December 22, 2011
Product type
Drugs
Office
Department of Health and Human Services
Person
  • Michael Dutcher (Acting Assistant Commissioner)
View Company Profile

ID · 2b9fd47e-8eef-4ff7-b8cd-0d532e25ea4f

Violation Codes10
21 U.S.C. 321(g)(1)(B)21 U.S.C. 331(d)21.U.S.C. 355(a)21 U.S.C. 355(i)21 U.S.C. 321(ff)(1)21 U.S.C. 321(p)21 U.S.C. 352(f)(1)21 U.S.C. 301(d)21 U.S.C. 33221 U.S.C. 334

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Quincy Bioscience Manufacturing Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.